The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Five-year overall survival among patients with metastatic renal cell carcinoma: Results of Russian population-based study RENSUR5.
 
Ilya Tsimafeyeu
Leadership - Ruspharmtech
Stock and Other Ownership Interests - Ilgen; Ruspharmtech
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Ruspharmtech
Research Funding - Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Kidney Cancer Research Bureau; Oncomax LLC; Ruspharmtech
 
Tatiana Zolotareva
No Relationships to Disclose
 
Sergey Varlamov
No Relationships to Disclose
 
Ruslan Zukov
No Relationships to Disclose
 
Liubov Yu Vladimirova
No Relationships to Disclose
 
Vladislav Petkau
No Relationships to Disclose
 
Mikhail Mazhbich
No Relationships to Disclose
 
Galina Statsenko
No Relationships to Disclose
 
Sufia Safina
No Relationships to Disclose
 
Igor Zaitsev
No Relationships to Disclose
 
Dina Sakaeva
No Relationships to Disclose
 
Alexander Popov
No Relationships to Disclose
 
Pavel Borisov
No Relationships to Disclose